A multicenter phase II trial of thalidomide and celecoxib for patients with relapsed and refractory multiple myeloma

HM Prince, L Mileshkin, A Roberts, V Ganju, C Underhill, J Catalano, R Bell, JF Seymour, D Westerman, PJ Simmons, K Lillie, AD Milner, J Di Iulio, JB Zeldis, R Ramsay